Scarica l'app Stockscreener
41.92
1.76%
-0.75
Dopo l'orario di chiusura:
41.93
0.010
+0.02%
Precedente Chiudi:
$42.67
Aprire:
$42.26
Volume 24 ore:
766.09K
Relative Volume:
0.93
Capitalizzazione di mercato:
$3.23B
Reddito:
$13.17M
Utile/perdita netta:
$-199.06M
Rapporto P/E:
-15.30
EPS:
-2.74
Flusso di cassa netto:
$-156.53M
1 W Prestazione:
+2.85%
1M Prestazione:
+4.41%
6M Prestazione:
+9.74%
1 anno Prestazione:
+1.97%
Intervallo 1D:
$41.45
$42.72
Intervallo di 1 settimana:
$40.79
$43.33
Portata 52W:
$26.74
$46.00
Xenon Pharmaceuticals Inc Stock (XENE) Company Profile
Nome
Xenon Pharmaceuticals Inc
Settore
Industria
Telefono
(604) 484-3300
Indirizzo
200 - 3650 GILMORE WAY, BURNABY
Confronta XENE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
XENE
Xenon Pharmaceuticals Inc
|
41.92 | 3.29B | 13.17M | -199.06M | -156.53M | -2.74 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Xenon Pharmaceuticals Inc Stock (XENE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-03 | Ripresa | Wells Fargo | Overweight |
| 2025-05-07 | Iniziato | Chardan Capital Markets | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-10-10 | Ripresa | Raymond James | Outperform |
| 2024-10-01 | Iniziato | H.C. Wainwright | Buy |
| 2024-01-04 | Iniziato | Citigroup | Buy |
| 2023-12-08 | Iniziato | Robert W. Baird | Outperform |
| 2023-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2023-04-25 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-12-14 | Iniziato | Goldman | Buy |
| 2022-12-12 | Iniziato | Cowen | Outperform |
| 2022-11-28 | Iniziato | Wells Fargo | Overweight |
| 2022-10-19 | Iniziato | Raymond James | Outperform |
| 2022-08-29 | Iniziato | BofA Securities | Buy |
| 2022-07-21 | Iniziato | JP Morgan | Overweight |
| 2021-10-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-10-02 | Iniziato | SVB Leerink | Outperform |
| 2020-07-21 | Iniziato | Needham | Buy |
| 2020-06-01 | Ripresa | Jefferies | Buy |
| 2020-03-25 | Iniziato | Wedbush | Outperform |
| 2020-01-08 | Iniziato | William Blair | Outperform |
| 2019-09-20 | Iniziato | Guggenheim | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2017-03-13 | Iniziato | Jefferies | Buy |
| 2016-10-21 | Iniziato | Stifel | Buy |
| 2016-09-26 | Iniziato | Guggenheim | Buy |
| 2016-04-14 | Reiterato | Jefferies | Buy |
| 2015-10-30 | Ripresa | Jefferies | Buy |
| 2014-12-02 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Xenon Pharmaceuticals Inc Borsa (XENE) Ultime notizie
Technical signs of recovery in Xenon Pharmaceuticals Inc.Trade Exit Summary & Reliable Intraday Trade Alerts - newser.com
What MACD and RSI say about Xenon Pharmaceuticals Inc.July 2025 Setups & Technical Confirmation Trade Alerts - newser.com
What valuation multiples suggest for Xenon Pharmaceuticals Inc. stock - newser.com
State of New Jersey Common Pension Fund D Increases Stock Holdings in Xenon Pharmaceuticals Inc. $XENE - MarketBeat
Xenon Pharmaceuticals Inc. $XENE Position Trimmed by Jennison Associates LLC - MarketBeat
When is the best time to exit Xenon Pharmaceuticals Inc.2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Tools to monitor Xenon Pharmaceuticals Inc. recovery probabilityWeekly Investment Report & Safe Entry Point Identification - newser.com
Chart overlay techniques for tracking Xenon Pharmaceuticals Inc.July 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
Why Xenon Pharmaceuticals Inc. stock is trending among retail tradersJuly 2025 Retail & Weekly Momentum Picks - newser.com
Will Xenon Pharmaceuticals Inc. stock continue dividend increasesJuly 2025 Macro Moves & Long-Term Growth Portfolio Plans - newser.com
Traders Buy High Volume of Xenon Pharmaceuticals Put Options (NASDAQ:XENE) - MarketBeat
Intraday pattern recognizer results for Xenon Pharmaceuticals Inc.July 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Xenon Pharmaceuticals Inc. (XENE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Xenon Pharmaceuticals Inc. (XENE) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Xenon Pharmaceuticals (XENE) Expected to Announce Earnings on Monday - MarketBeat
Will Xenon Pharmaceuticals Inc. price bounce be sustainableWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Xenon Pharmaceuticals’ XEN1101: A Promising Epilepsy Treatment in the Making - The Globe and Mail
Xenon Pharmaceuticals Inc. (XENE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Xenon Pharmaceuticals to Announce Q3 2025 Financial Results - TipRanks
Xenon Pharmaceuticals (NASDAQ: XENE) schedules Nov. 3 call on Q3 financial results - Stock Titan
Xenon Pharmaceuticals Inc Azioni (XENE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):